SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of report (Date of earliest event reported): October 24, 2001
MEDTOX SCIENTIFIC, INC.
(Exact Name of Registrant as Specified in Its Charter)
Minnesota
(State or Other Jurisdiction of Incorporation)
1-11394 95-3863205
(Commission File Number) (I.R.S. Employer Identification Number)
402 West County Road D
St. Paul, Minnesota 55112
(Address of Principal Executive Offices) (Zip Code)
(651) 636-7466
(Registrant's Telephone Number, Including Area Code)
Not Applicable
(Former Name or Former Address, if Changed Since Last Report)
Item 2. Acquisition or Disposition of Assets.
On October 25, 2001, MEDTOX Scientific, Inc. issued a press release
announcing the completion of an acquisition of a pediatric lead testing
laboratory, Leadtech Corporation. The terms of the acquisition are detailed in
the press release, a copy of which is filed as Exhibit 99 to this Form 8-K.
Item 7. Financial Statements and Exhibits.
(a) Financial Statements of Business Acquired:
-----------------------------------------
*
(b) Pro Forma Financial Information:
-------------------------------
*
(c) Exhibits:
--------
See Exhibit Index on page following Signatures.
* The financial statements and pro forma financial information regarding the
acquired business will be filed within 60 days after the date of this report on
Form 8-K, if required.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
MEDTOX SCIENTIFIC, INC.
Date: November 7, 2001 By: /s/ Richard J. Braun
-----------------------------------
Richard J. Braun
President and Chief Executive Officer
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
EXHIBIT INDEX
to
FORM 8-K
MEDTOX SCIENTIFIC, INC.
- -------------------------------------------------------------------------------
Exhibit
Number Exhibit Description
2 Stock Purchase Agreement by and among
MEDTOX Scientific, Inc., Raoul D. Rudelli, M.D,
Karl Verebey, Ph.D., Michael Greenstein, and
Leadtech Corporation
4 Promissory Note for $400,000 dated October 16, 2001 by
MEDTOX Scientific, Inc. in favor of Raoul D. Rudelli, M.D.
(Not included, but available to be provided upon request,
Promissory Notes under identical terms, in favor of Karl
Verebey, and Michael Greenstein.)
99 Press release dated October 25, 2001